BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
T cell differentiation
,
Diabetes mellitus
,
Heart
,
Laryngoscope
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cilostazol
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
PDE4B
PPP2CA
DDX27
ROCK2
CYP51A1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN
response to organic substance
organic cyclic compound binding
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Hearts of rats exposed variety of toxicants
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulatio…
Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology…
Cilostazol pretreatment prevents PTSD-related anxiety behavior through reduction of hippocampal neur…
Do Patients With Arterial Occlusive Disease of Different Etiologies Benefit Equally From Cilostazol?
Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NAS…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cilostazol for HFpEF
The Use of Cilostazol in Patients With Diabetic Nephropathy
Evaluation of Cilostazol in Combination With L-Carnitine
Cilostazol and Methotrexate in Rheumatoid Arthritis
Cilostazol Following Peripheral Endovascular Procedures
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ